JIP
EDIT icon

Jaffetilchin Investment Partners’s Editas Medicine EDIT Stock Holding History

Jaffetilchin Investment Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-738
Closed -$2.52K – 619
2024
Q3 		$2.52K Buy
+738
New +$3.21K ﹤0.01% 1149

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jaffetilchin Investment Partners's EDIT Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 738 shares — an estimated $2.52K sold.

Jaffetilchin Investment Partners first reported a position in EDIT in Q3 2024 and held it in 1 quarter. The position peaked at $2.52K in Q3 2024. 207 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Jaffetilchin Investment Partners reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 738 Editas Medicine shares in Q4 2024, an estimated $2.52K.
  • Jaffetilchin Investment Partners first reported a position in Editas Medicine in Q3 2024 and held it in 1 quarter.
  • Jaffetilchin Investment Partners's Editas Medicine position peaked at $2.52K in Q3 2024.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.